Publication Topic : Access to Medicines
HIV/AIDS and Pharmaceutical Pricing
This info sheet is one in a series of seven info sheets on the federal regulation of pharmaceutical prices in Canada. Health Spending and the Pharmaceutical Industry Controlling Medicine Prices: Evolution of Canadian Law Patented Medicine Prices Review Board Preventing Excessive Pricing of Patented Medicines Jurisdiction of the PMPRB Pricing of HIV/AIDS Drugs Trends in … Read more
Letter to the Standing Committee on Industry, Science and Technology re: Bill C-9, An Act to amend the Patent Act and the Food and Drugs Act
“I write to follow up on our previous submissions to the Standing Committee regarding Bill C-9, Canada’s laudable initiative to implement the WTO General Council Decision of August 30, 2003 to enable countries lacking sufficient pharmaceutical manufacturing capacity to ‘make effective use’ of compulsory licensing to obtain lower cost generic pharmaceutical products manufactured in Canada…”
Letter to the Standing Committee on Industry, Science and Technology re: Bill C-9 and the issue of NGO procurement of Canadian-made phramaceuticals
“As was requested by the Committee when we appeared before you on February 26, 2004, we have provided the Committee with our supplementary submissions regarding the alternatives to the ‘right of refusal’ that had been proposed to the Committee… “However, discussions at subsequent Committee meetings have indicated that Committee members are under a fundamental misapprehension … Read more
Global Access to Medicines: Will Canada Meet the Challenge? – Supplementary submission to the Standing Committee on Industry, Science and Technology regarding Bill C-9, An Act to amend the Patent Act and the Food and Drugs Act
The Standing Committee has asked that we provide our views regarding the “alternatives” to the right of refusal that have been put forward by other witnesses appearing before the Committee. We address several of the most important points that have been put before the Committee.